OREANDA-NEWS. September 12, 2011. SORAINEN acted as Estonian counsel for the EBRD in relation to the equity investment stage of a EUR 20 million financial package for a pharmaceutical company active in the CIS, reported the press-centre of SORAINEN.  

 The overall investment is a combination of equity and debt to finance expansion of the company in CIS countries and to refinance the company's short-term debt.

Advice was provided by specialist counsel Kadri Kallas with support of partner Reimo Hammerberg.